ABSTRACT
Background: The psychological effects of the Covid-19 disease continue. Fear of the disease affects individuals' attitudes towards Covid-19 vaccines. Objectives: To determine the effect of fear of Covid-19 on individuals' attitudes towards the Covid-19 vaccine. Methods: It is a descriptive type of research from quantitative research methods. The data of the study were collected online between 1 July and 31 August 2021 using the snowball sampling technique. The sample of the study consisted of 221 people who accepted to participate in the study voluntarily and filled out the form completely within the specified period. Data collection tools are "Participant Information Form”, "Covid-19 Fear Scale” and "Attitudes towards Covid-19 Vaccine Scale”. Results: The mean score of the individuals participating in the study on the Covid-19 fear scale was 17.84 ± 6.65;Positive attitude towards the Covid-19 vaccine sub-dimension mean score was 3.79 ± 1.12;The mean score of the negative attitude sub-dimension towards the Covid-19 vaccine was determined as 3.57 ± 1.23, a positive, significant (r =.28;p =.000) relationship was found between the variables of fear of Covid-19 and positive attitude towards the Covid-19 vaccine. In addition, it was observed that fear of Covid-19 had a significant effect on the level of positive attitude towards the Covid-19 vaccine (t = 4.396;p =.000). Conclusion: Fear of Covid-19 has positively affected individuals' attitudes towards the Covid-19 vaccine. © 2023, Dokuz Eylul University. All rights reserved.
ABSTRACT
AIM: The impact of COVID-19 pandemic is pronounced in each healthcare process, including the management of breast cancer. The anxiety of COVID-19 changes patient preferences and some delay in routine controls and surgical managements occur. Some disintegration in medical care is to be expected during the pandemic, but the new coping strategies are needed in order to avoid delayed diagnosis of breast cancer. METHODS: A total number of 140 patients assigned for biopsy and diagnosed with breast cancer in our tertiary clinic between December 1st and August 31st were classified into 3 groups;A (December-February), B (March-May) and C (June-August) in order to compare the stage of breast cancer at the time of diagnosis before, during and after the peak period of pandemic. Clinical stage and age at presentation, family history of breast, ovarian and other types of cancer, BRCA (genetic testing), menopausal status, side of involvement (uni- or bilateral), histopathologic subtype, receptor positivity and molecular subtype were recorded for each patient. RESULTS: Group A included 20 stage I (27.77 %), 32 stage II (44.44 %), 16 stage III (22.22 %) and 4 stage IV (5.55 %) breast cancer patients. Group B had 5 stage I (22.72 %), 8 stage II (36.36 %), 7 stage III (31.81 %) and 2 stage IV (9.09 %) breast cancer patients. Whereas in group C there were 4 stage I (8.69 %), 21 stage II (45.65 %), 16 stage III (34.78 %) and 5 stage IV (10.86 %) patients with breast cancer. The number of late-stage cancer patients in group C was significantly higher in comparison with the other groups (p<0.05). CONCLUSION: We speculate that the change in incidence of breast cancer by stage is attributable to a delay in the diagnosis of breast cancer due to COVID-19 related restrictions and presentation of new cases at more advanced stages once the restrictions were eased. KEY WORDS: Biopsy, Breast cancer, COVID-19, PandemicStage.
ABSTRACT
Objectives: It was aimed to compare Alpha-1 antitrypsin (AAT), Alpha-1 acid glycoprotein (AGP), Total Immunoglobulin M (Total IgM), Total Immunoglobulin G (Total IgG), Galectin-3 (Gal3), and severe acute respiratory syndrome coronavirus 2 IgG (SARS-CoV-2 IgG) levels in patients with COVID-19 and healthy individuals. Methods: The study included a total of 86 participants, 44 patients diagnosed with COVID-19 by real-time reverse transcription-polymerase chain reaction (rRT-PCR) test and 42 as the control group. AAT, AGP, Total IgM, and Total IgG levels were measured using the immunoturbidimetric method. Gal3 and SARS-CoV-2 IgG levels were measured using the chemiluminescent microparticle immunoassay method. Results: AAT, AGP, Total IgG, Gal3, and SARS-CoV-2 IgG levels were found to be significantly higher in the patient group compared to the control group (p<0.001 for all tests). In the patient group, there was a moderate correlation between AAT-AGP and SARS-CoV-2 IgG-AAT (r=0.692;r=0.561, respectively). Conclusions: High levels of AAT, AGP, Total IgG, Gal3, and SARS-CoV-2 IgG in the patient group and correlations between variables suggest that these parameters may be involved in the pathogenesis of the disease and provide an idea about the prognosis of the disease. However, new studies on this subject are needed in order to clearly reveal the laboratory tests related to the clinical course of the disease. © 2021 De Gruyter. All rights reserved.
ABSTRACT
AIM: The impact of COVID-19 pandemic is pronounced in each healthcare process, including the management of breast cancer. The anxiety of COVID-19 changes patient preferences and some delay in routine controls and surgical managements occur. Some disintegration in medical care is to be expected during the pandemic, but the new coping strategies are needed in order to avoid delayed diagnosis of breast cancer. METHODS: A total number of 140 patients assigned for biopsy and diagnosed with breast cancer in our tertiary clinic between December 1st and August 31st were classified into 3 groups;A (December-February), B (March-May) and C (June-August) in order to compare the stage of breast cancer at the time of diagnosis before, during and after the peak period of pandemic. Clinical stage and age at presentation, family history of breast, ovarian and other types of cancer, BRCA (genetic testing), menopausal status, side of involvement (uni- or bilateral), histopathologic subtype, receptor positivity and molecular subtype were recorded for each patient. RESULTS: Group A included 20 stage I (27.77 %), 32 stage II (44.44 %), 16 stage III (22.22 %) and 4 stage IV (5.55 %) breast cancer patients. Group B had 5 stage I (22.72 %), 8 stage II (36.36 %), 7 stage III (31.81 %) and 2 stage IV (9.09 %) breast cancer patients. Whereas in group C there were 4 stage I (8.69 %), 21 stage II (45.65 %), 16 stage III (34.78 %) and 5 stage IV (10.86 %) patients with breast cancer. The number of late-stage cancer patients in group C was significantly higher in comparison with the other groups (p<0.05). CONCLUSION: We speculate that the change in incidence of breast cancer by stage is attributable to a delay in the diagnosis of breast cancer due to COVID-19 related restrictions and presentation of new cases at more advanced stages once the restrictions were eased. KEY WORDS: Biopsy, Breast cancer, COVID-19, PandemicStage.
ABSTRACT
The world has encountered a pandemic named Covid-19 that has affected people's lives in numerous dimensions. During this ongoing dramatic and stratified period, we have been shattered globally in various layers. As 12 students of the first Body-Oriented Clinical Psychology master's program at Maltepe University in Turkey, we experienced uncertainty caused by the pandemic accompanied with online Body-Oriented Psychotherapy classes. Our experiences in Turkey, mostly Istanbul between mid-March and June, 2020 can be an example of reacting with uncertainty to the unexpected Covid-19 pandemic and may highlight the role of the body coping. In this article, we intended to reflect our pandemic experiences of significant changes in our lives. We examined our perception of the new normal as 'Body-Oriented Clinical Psychology students' in our reflections with distinct and common experiences. In addition, we covered the experiences of body awareness, embodiment, emotions, and interpersonal relationships while coping with the coronavirus. Our reflections revealed that the uncertainty of online education and other circumstances during this time caused anxiety and anger, while body-oriented courses helped us feel regulated and attuned. Sharing our experiences and evaluating the effects of our education on these experiences of lock-downs were important in gaining a better understanding of the circumstances in order to determine helpful solutions. © 2021, Vesnu Publications. All rights reserved.
ABSTRACT
Due to the COVID-19 pandemic, almost all elective operations have been postponed. Therefore, only diseases that threaten life/organ have been treated. We desired to discuss the diagnosis and surgical reasons of the patients who were operated in the pediatric surgery clinic for emergency or urgent reasons during this pandemic period, and also the measures to protect the patient and healthcare professionals from COVID-19 infection.
ABSTRACT
At the beginning of 2020, COVID-19 spread rapidly all over the world. Social distancing has been one of the measures taken to prevent the disease from spreading, meaning employees and students have been forced to work remotely using communication tools. Within the design field, professionals and students working remotely were limited to using communication tools developed during the design process, finding ways to use these facilities in accordance with their practice routines in the physical environment. In this article, the tools used to conduct collaborative design processes remotely during the pandemic were examined through a questionnaire study. Even though designers have had to work digitally to maintain workflow during this period, positive experiences were observed when using the special tools. However, the transfer of tacit knowledge was restricted in design projects due to limited spatial communication. While many designers discovered they could already use the available tailored tools, many improvements were suggested through needs that were previously unknown becoming explicit. © 2021 Universidade do Vale do Rio dos Sinos. All rights reserved.